Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.8K
Lipids as Anchors01:32

Lipids as Anchors

7.1K
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
7.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Arthroscopic vs. open Broström-Gould procedure for chronic lateral ankle instability: a systematic review and meta-analysis.

Frontiers in surgery·2026
Same author

Polygenic risk score analysis of noise-induced hearing loss: An integrated cross-sectional and longitudinal study.

Hearing research·2026
Same author

Advances and Prospects of ZIF-Based Nanoplatforms for Therapeutic and Diagnosis Strategies in Endocrine Diseases.

ACS applied bio materials·2026
Same author

Sympathetic immunomodulation suppresses liver metastasis by maintaining the balance between norepinephrine concentration and the α2a/β2-AR ratio.

Cellular & molecular immunology·2026
Same author

AS1411 aptamer-functionalized, cell membrane-camouflaged nanoparticles for targeted tumor cells imaging in the Raman silent region.

Analytical and bioanalytical chemistry·2026
Same author

NRAC: an emerging nutrient-responsive regulator of tissue-specific fatty acid metabolism.

Biochemical and biophysical research communications·2026
Same journal

Hyocholic acids: Third bile acids for neonatal health.

Trends in molecular medicine·2026
Same journal

Clonal hematopoiesis in Alzheimer's brain: Protective, pathogenic, and context-dependent?

Trends in molecular medicine·2026
Same journal

Targeting amino acid metabolism in hepatocellular carcinoma.

Trends in molecular medicine·2026
Same journal

Turning perfusion into repair through ferroptosis blockade.

Trends in molecular medicine·2026
Same journal

CaMKK2: A tumor stress-integration node.

Trends in molecular medicine·2026
Same journal

Precision gene editing: From proof-of-concept to curative therapies.

Trends in molecular medicine·2026
查看所有相关文章

相关实验视频

Updated: Jan 12, 2026

Click-Chemistry Based Fluorometric Assay for Apolipoprotein N-acyltransferase from Enzyme Characterization to High-Throughput Screening
07:37

Click-Chemistry Based Fluorometric Assay for Apolipoprotein N-acyltransferase from Enzyme Characterization to High-Throughput Screening

Published on: May 13, 2020

2.3K

ANGPTL3/8:一个目标,多种脂质疾病.

Ren Zhang1

  • 1Center for Molecular Medicine and Genetics, Wayne State University Medical School, Detroit, MI 48202, USA.

Trends in molecular medicine
|October 30, 2025
PubMed
概括
此摘要是机器生成的。

选择性阻断血管类蛋白 (ANGPTL) 3/8复合物有效降低甘油三和提高高密度胆固醇. 这种方法显示出作为各种失脂症的精密治疗方法的希望.

关键词:
ANGPTL3 在线观看第八个角度在APOA5A5中使用.克雷布 (Crebh) 是一个小鱼.甘油三胺的使用方法

更多相关视频

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.3K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.7K

相关实验视频

Last Updated: Jan 12, 2026

Click-Chemistry Based Fluorometric Assay for Apolipoprotein N-acyltransferase from Enzyme Characterization to High-Throughput Screening
07:37

Click-Chemistry Based Fluorometric Assay for Apolipoprotein N-acyltransferase from Enzyme Characterization to High-Throughput Screening

Published on: May 13, 2020

2.3K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.3K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.7K

科学领域:

  • 生物化学和分子生物学
  • 心血管医学 心血管医学
  • 代谢障碍 代谢障碍 代谢障碍

背景情况:

  • 血管蛋白样蛋白 (ANGPTL) 3/8 综合体是三甘油代谢的关键调节者.
  • 脱脂症,以异常的脂质水平为特征,是心血管疾病的主要危险因素.
  • 目前的治疗方法在解决复杂的脂质干扰方面存在局限性.

研究的目的:

  • 评估选择性阻断ANGPTL3/8复合物的治疗潜力.
  • 研究ANGPTL3/8对抗作用对甘油三和高密度胆固醇水平的影响.
  • 探索ANGPTL3/8对抗性作为一种精确医学方法来治疗失脂症.

主要方法:

  • 抑制ANGPTL3/8复合体的作用.
  • 对脂质分区的评估.
  • 分析与脱脂症相关的临床和遗传数据.

主要成果:

  • 选择性阻断ANGPTL3/8复合物导致甘油三水平降低.
  • 在ANGPTL3/8阻塞后,HDL胆固醇水平增加.
  • 证据支持ANGPTL3/8对抗性对于混合性失脂血症和单一性高甘油三血症等疾病.

结论:

  • ANGPTL3/8对抗性是一种有前途的治疗策略,用于失脂症.
  • 这种方法通过纠正基本的脂质分区障碍来提供精确治疗.
  • 进一步的研究支持其在遗传性和获得性脂质失调症中的应用.